Skip to main content
LEAD logo

LEAD

Security and trust center evidence

Transform collaboration, networking, and knowledge sharing across your organization, streamline mentorship, onboarding, and enhancing

lead.appLast verified 2 Nov 2026

Summary

LEAD has , and 1 expired in the CertReports index, last verified 2 Nov 2026. The strongest row is EU-US Data Privacy Framework: Inactive. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

LEAD's only recorded listing, in the EU-US Data Privacy Framework registry, is inactive, as of 17 Sep 2026. The EU-US Data Privacy Framework listing for LEAD was originally issued 14 Sep 2020, as of 17 Sep 2026. No expiration date is recorded for LEAD's EU-US Data Privacy Framework listing, as of 17 Sep 2026. No public evidence found for SOC 2, ISO/IEC 27001, GDPR, or HIPAA for LEAD, as of 17 Sep 2026. No public evidence found for PCI DSS, FedRAMP, or CSA STAR for LEAD, as of 17 Sep 2026.

  • EU-US Data Privacy Framework - listing inactive, as of 17 Sep 2026.
  • EU-US Data Privacy Framework - originally issued 14 Sep 2020; no expiration date recorded.
  • No public evidence found for SOC 2, ISO/IEC 27001, GDPR, HIPAA, PCI DSS, FedRAMP, or CSA STAR, as of 17 Sep 2026.

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 19 Sep 2026; it is regenerated whenever a row changes.

Evidence count

0verified rows

knowledge sharingmentorshiponboardingteam collaboration

Compliance grid

No public evidence yet for HIPAA, SOC 2, GDPR, FedRAMP, PCI DSS, ISO 27001, CSA STAR, Cyber Essentials, ISO 27701, ISO 42001. This does not mean the vendor lacks them; it means nothing public was found at the last check.

Subprocessors

No subprocessor list captured yet.

Change history

  1. 18 Sep 2026First indexed by CertReports1 evidence row across 1 framework entered the index.

Evidence against regulations

All regulations for LEAD

How much of each regulation’s vendor requirements LEAD’s public evidence reaches.

All articles